A rare opportunity for ASOs
Dan Williams, CEO of SynaptixBio, explains the science behind antisense oligonucleotides (ASOs) and the challenges and opportunities in using them to tackle rare diseases such as H-ABC. Gene silencing’ is a term used to describe the process of stopping a specific gene from making its associated protein. It is different… Read More